>I hope they think about "pump head" when they design the CABG trial. They could find ATryn could help with something else, other than giving a buffer to heparin resistance.<
A good phase-3 trial is one that asks a specific question and answers it. If Ovation wants to pursue CABG/COG (a.k.a. pump head), it will almost certainly be in a separate trial from the one in CABG/HR.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”